Insulet Co. (NASDAQ:PODD – Get Free Report) Director Timothy J. Scannell sold 7,000 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $190.51, for a total value of $1,333,570.00. Following the sale, the director now owns 35,586 shares in the company, […]
Scout Investments Inc. reduced its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 14.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 51,844 shares of the medical instruments supplier’s stock after selling 8,413 shares during the quarter. Scout Investments Inc. […]
Scout Investments Inc. reduced its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 14.0% during the fourth quarter, Holdings Channel reports. The firm owned 51,844 shares of the medical instruments supplier’s stock after selling 8,413 shares during the period. Scout Investments Inc.’s holdings in Insulet were worth $11,249,000 at the end of the most […]
CenterBook Partners LP boosted its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 108.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 9,181 shares of the medical instruments supplier’s stock after acquiring an additional 4,779 shares during the quarter. CenterBook Partners LP’s holdings in Insulet were worth $1,992,000 at the end of […]
Rhenman & Partners Asset Management AB cut its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 56.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,000 shares of the medical instruments supplier’s stock after selling 25,000 shares during the period. Rhenman & Partners […]